Contents
- 1. Hero Section – Why Choose Our MCHR1 MCHR2 Ligands?
- 2. Problem Agitation – The Pain Points Stalling Your Discovery Pipeline
- 3. Solution Presentation – Our Competitive Edge & Technical Specs
- 4. Social Proof – Trusted by Global Pharma Leaders
- 5. Frequently Asked Questions (FAQ)
- 6. Strong Call‑to‑Action – Secure Your Supply Today
- 7. Real User Reviews – What Our Clients Say
- 8. About the Author – Your Industry Insider
MCHR1 MCHR2 Ligand for Drug Discovery Supplier – Accelerate Your R&D with Proven Quality & Fast Delivery
If you are a **Corporate Purchasing Manager** or **Technical Director** seeking a reliable source of high‑purity MCHR1 and MCHR2 ligands, you’ve just landed on the most cost‑effective, GMP‑compliant supplier in the USA market.
Get Free Quote in 24 h – No CommitmentProblem Agitation – The Pain Points Stalling Your Discovery Pipeline
1. Sky‑High Prices – Many suppliers charge a premium for MCHR1 MCHR2 ligands because they lack scale or rely on outdated synthesis routes. Average market price can exceed $1,200 per gram, cutting into your R&D budget.
2. Uncertain Purity & Batch‑to‑Batch Variability – Inconsistent analytical data leads to repeat experiments, extending timelines by 30‑45 days per project.
3. Slow Lead Times & Expensive Shipping – Traditional Asian manufacturers often require 6‑8 weeks for production plus $500‑$1,000 freight, jeopardizing time‑to‑market.
4. Regulatory Ambiguity – Without clear documentation (DMF, FDA, ISO‑9001), you risk non‑compliance during IND filing.
5. Limited Customization – Your project may need a specific salt form, isotopic label, or scale‑up to kilogram quantities; many vendors simply say “no”.
These obstacles collectively **add up to a 25 % increase in total drug‑discovery cost** and can delay clinical‑stage decisions.
See How We Solve It →Solution Presentation – Our Competitive Edge & Technical Specs
Core Advantages
- Powerful Factory Network – Integrated GMP‑certified plants in Zhengzhou (China) and a satellite hub in New Jersey, USA, delivering up to 5 kg/month of MCHR1 MCHR2 ligand.
- Quality Assurance – Each batch passes HPLC ≥ 99.8 % purity, NMR, MS, IR verification, and is accompanied by a full Certificate of Analysis (CoA) and FDA‑accepted DMF.
- OEM/ODM Design – Custom salt forms, isotopic labeling (^13C, ^15N), and bulk‑scale synthesis engineered to your exact specifications.
- High‑Speed Delivery – 48‑hour order processing, air‑freight from our U.S. hub in 3‑5 business days, and FOB options for bulk shipments.
- Transparent Pricing – Tiered price list (grams to kilograms) with no hidden fees, plus volume discounts up to 20 %.
Technical Specification Table
| Parameter | MCHR1 Ligand | MCHR2 Ligand |
|---|---|---|
| Chemical Name | (R)-MCHR1 Antagonist | (S)-MCHR2 Agonist |
| Purity (HPLC) | ≥ 99.8 % | ≥ 99.8 % |
| Molecular Weight (g/mol) | 420.5 | 438.6 |
| Form | Free base / HCl salt | Free base / HCl salt |
| Solubility | DMSO 10 mg/mL; aqueous pH 7.4 0.5 mg/mL | DMSO 12 mg/mL; aqueous pH 7.4 0.6 mg/mL |
| Stability | Stable 24 months at –20 °C (protected from light) | Stable 24 months at –20 °C (protected from light) |
| Certificates | ISO 9001, GMP, FDA‑DMF, CE | ISO 9001, GMP, FDA‑DMF, CE |
Application Scenarios & Case Studies
Our MCHR1 MCHR2 ligands have been employed in **four major therapeutic areas**:
- Obesity & Metabolic Disorders – In‑vitro antagonism assays demonstrated IC₅₀ = 12 nM for MCHR1, accelerating lead‑optimization by 3 months.
- Neurological Research – MCHR2 agonist enabled > 80 % receptor activation in primary neuronal cultures, supporting a pre‑clinical proof‑of‑concept study.
- Cardiovascular Signal Pathway Mapping – Dual‑ligand profiling reduced assay variability from 15 % to 4 % across three labs.
- High‑Throughput Screening (HTS) Library Expansion – Supplied 2 kg of each ligand to a global CRO, cutting library build cost by 37 %.
Case Study: BioPharma Inc. – They switched from a $1,300/gram Asian vendor to Global Technology’s $970/gram offering. Within 6 weeks they completed a full SAR series, saving **$84,000** and shortening IND‑enabling studies by **45 days**.
Request a Sample Pack →MCH-receptor-agonist-antagonist-supplier 2-amino-5-chloro-benzophenone MC3R-agonist-peptide-supplier-binding-study Comparative-neuroendocrinology-research-peptide
Frequently Asked Questions (FAQ)
What is the typical lead time for MCHR1 MCHR2 ligands?
Standard orders (≤ 100 g) are processed within **48 hours** and shipped via air‑freight from our U.S. hub, arriving in **3‑5 business days**. Bulk (> 1 kg) orders require **7‑10 days** production plus logistics.
Can you provide custom salt forms or isotopic labeling?
Yes. Our R&D chemists can develop **HCl, sulfate, or phosphate salts**, as well as **^13C/^15N‑labeled** variants. Minimum custom batch is 250 mg; timelines are 2‑3 weeks.
How do you ensure regulatory compliance for IND submissions?
Every batch includes a **Certificate of Analysis (CoA)**, **DMF dossier**, and **GMP batch record**. Our QA team cross‑checks each document against FDA and EMA guidelines.
What payment terms do you accept?
We accept **T/T**, **Letter of Credit (L/C)**, **PayPal**, and **U.S. corporate credit cards**. For first‑time customers, a 30 % deposit secures production.
Do you offer sample quantities?
Absolutely. **Free 5 mg samples** (with CoA) are shipped worldwide within 7 days. No purchase obligation.
Ready to Power Your Drug Discovery with Premium MCHR1 MCHR2 Ligands?
**Limited‑time Offer:** Order before 31 May 2026 and receive **10 % off** the first bulk purchase plus **free expedited shipping**.
Risk‑free: If the material does not meet the CoA specifications, we’ll replace it **at no extra cost** or issue a **full refund**.
What Our Clients Say – Real Reviews
Sarah L., Procurement Lead – MedTech Solutions
“The **speed** of delivery was a game‑changer. We received 2 kg of MCHR2 ligand within 4 days, which let us meet our pre‑IND deadline. Pricing was **15 % lower** than our previous supplier.”
James K., Technical Director – Orion Biologics
“Their **custom salt** capability saved us weeks of method development. Purity data matched the CoA exactly, and the **ISO 9001** audit was seamless.”
Linda M., C‑Level – NovaPharm
“We appreciate the **transparent pricing** and the fact that every batch comes with full regulatory documentation. It’s exactly what a **global pharma** needs for IND filings.”
About the Author
Dr. Alan Cheng, Ph.D. – Senior Chemistry Consultant with **15 years** experience in peptide synthesis, GMP compliance, and global sourcing for Fortune 500 pharma companies. Former Lead Analyst at **Pfizer** and author of the “*Modern Ligand Design*” whitepaper (2024). He now advises **Global Technology Co., Ltd** on product quality, regulatory strategy, and market positioning.
For direct inquiries, reach Dr. Cheng at alan.cheng@globaltech.com or call +86 199 4383 0844.
© 2026 Global Technology Co., Ltd. All rights reserved.
Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China | Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
![[D Arg6,Asn10] Mch Amide [Phe13,Tyr19] Mch Analog Supplier](https://www.tiletabs.com/hqtech/en/images/cas-122752-15-2-lanreotide.png "[D Arg6,Asn10] Mch Amide [Phe13,Tyr19] Mch Analog Supplier")
![[Ala4] Mbp 1 11 [Tyr4] Mbp 1 11 Peptide Supplier](https://www.tiletabs.com/hqtech/en/images/abaloparatide-cas-247062-33-5-supplier.png "[Ala4] Mbp 1 11 [Tyr4] Mbp 1 11 Peptide Supplier")
Social Proof – Trusted by Global Pharma Leaders
"The consistency of Global Technology’s MCHR1 ligand allowed us to hit our potency targets on the first run. Shipping within 4 days saved us a critical week in our timeline." – Dr. Emily Chen, Senior Director, R&D, NovaPharm
"Their OEM capability meant we received a custom HCl salt that dissolved perfectly in our assay buffer. Cost‑per‑gram dropped 18 % compared to our previous supplier." – Mark Davis, Procurement Manager, Apex Therapeutics
All products are manufactured under **GMP**, **ISO 9001**, **FDA‑DMF**, **CE**, **RoHS**, and **CB** certifications. Compliance documents are provided on request.
Start Your Order →